223 related articles for article (PubMed ID: 12522140)
1. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140
[TBL] [Abstract][Full Text] [Related]
2. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
[TBL] [Abstract][Full Text] [Related]
3. Involvement of GSK-3beta and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells.
Takahashi-Yanaga F; Mori J; Matsuzaki E; Watanabe Y; Hirata M; Miwa Y; Morimoto S; Sasaguri T
J Biol Chem; 2006 Dec; 281(50):38489-97. PubMed ID: 17046823
[TBL] [Abstract][Full Text] [Related]
4. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest.
Bai J; Nakamura H; Ueda S; Kwon YW; Tanaka T; Ban S; Yodoi J
J Biol Chem; 2004 Sep; 279(37):38710-4. PubMed ID: 15247282
[TBL] [Abstract][Full Text] [Related]
5. DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice.
Takahashi-Yanaga F; Yoshihara T; Jingushi K; Igawa K; Tomooka K; Watanabe Y; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Sasaguri T
Biochem Pharmacol; 2014 Jun; 89(3):340-8. PubMed ID: 24670930
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.
Diehl JA; Cheng M; Roussel MF; Sherr CJ
Genes Dev; 1998 Nov; 12(22):3499-511. PubMed ID: 9832503
[TBL] [Abstract][Full Text] [Related]
7. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
8. Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest.
Wang JS; Wang CL; Wen JF; Wang YJ; Hu YB; Ren HZ
World J Gastroenterol; 2008 Jul; 14(25):3982-9. PubMed ID: 18609681
[TBL] [Abstract][Full Text] [Related]
9. Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells.
Yasmin T; Takahashi-Yanaga F; Mori J; Miwa Y; Hirata M; Watanabe Y; Morimoto S; Sasaguri T
Biochem Biophys Res Commun; 2005 Dec; 338(2):903-9. PubMed ID: 16243295
[TBL] [Abstract][Full Text] [Related]
10. Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo.
Kubokura N; Takahashi-Yanaga F; Arioka M; Yoshihara T; Igawa K; Tomooka K; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Matsumoto T; Kitazono T; Sasaguri T
J Pharmacol Sci; 2015 Apr; 127(4):446-55. PubMed ID: 25913757
[TBL] [Abstract][Full Text] [Related]
11. Differentiation-inducing factor-1 suppresses cyclin D1-induced cell proliferation of MCF-7 breast cancer cells by inhibiting S6K-mediated signal transducer and activator of transcription 3 synthesis.
Tetsuo F; Arioka M; Miura K; Kai M; Kubo M; Igawa K; Tomooka K; Takahashi-Yanaga F; Nishimura F; Sasaguri T
Cancer Sci; 2019 Dec; 110(12):3761-3772. PubMed ID: 31553107
[TBL] [Abstract][Full Text] [Related]
12. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
Ong CS; Zhou J; Ong CN; Shen HM
Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
[TBL] [Abstract][Full Text] [Related]
13. Differentiation-inducing factor-1 suppresses the expression of c-Myc in the human cancer cell lines.
Jingushi K; Nakamura T; Takahashi-Yanaga F; Matsuzaki E; Watanabe Y; Yoshihara T; Morimoto S; Sasaguri T
J Pharmacol Sci; 2013; 121(2):103-9. PubMed ID: 23357875
[TBL] [Abstract][Full Text] [Related]
14. cAMP-induced degradation of cyclin D3 through association with GSK-3beta.
Naderi S; Gutzkow KB; Låhne HU; Lefdal S; Ryves WJ; Harwood AJ; Blomhoff HK
J Cell Sci; 2004 Aug; 117(Pt 17):3769-83. PubMed ID: 15252116
[TBL] [Abstract][Full Text] [Related]
15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
Xu G; Li Y; Yoshimoto K; Wu Q; Chen G; Iwata T; Mizusawa N; Wan C; Nie X
Toxicol Lett; 2014 Jan; 224(3):362-70. PubMed ID: 24231000
[TBL] [Abstract][Full Text] [Related]
16. c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1.
Güller M; Toualbi-Abed K; Legrand A; Michel L; Mauviel A; Bernuau D; Daniel F
World J Gastroenterol; 2008 Nov; 14(41):6339-46. PubMed ID: 19009649
[TBL] [Abstract][Full Text] [Related]
17. Critical role of the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway in recovery from anthrax lethal toxin-induced cell cycle arrest and MEK cleavage in macrophages.
Ha SD; Ng D; Pelech SL; Kim SO
J Biol Chem; 2007 Dec; 282(50):36230-9. PubMed ID: 17951252
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation.
Rössig L; Badorff C; Holzmann Y; Zeiher AM; Dimmeler S
J Biol Chem; 2002 Mar; 277(12):9684-9. PubMed ID: 11779850
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
Masamha CP; Benbrook DM
Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]